Home > Drugs A – Z > Gadobenate Dimeglumine (By injection)

Gadobenate Dimeglumine (By injection)

Used in magnetic resonance imaging (MRI) scans. Helps your doctor to see images of your brain, spine, and other parts of your body. This medicine is a gadolinium-based contrast agent (GBCA).

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Brand names include
Drug classes About this
Radiological Ionic Contrast Media

What works? Research summarized

Evidence reviews

Comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MRI Screening: a meta-analysis

BACKGROUND: As a common and essential contrast medium at present, gadobenate dimeglumine has shown better performance than some other agents when applied to Breast Magnetic Resonance Imaging Screening (Breast MRI Screening). Nevertheless, reports on the diagnostic performance of these two mediums (gadobenate dimeglumine and gadopentetate dimeglumine) are not completely consistent.

Lower Limb Peripheral Arterial Disease: Diagnosis and Management [Internet]

Lower limb peripheral arterial disease (known in the document as peripheral arterial disease, PAD) is a marker for an increased risk of potentially preventable cardiovascular events even when it is asymptomatic. If it becomes symptomatic it can lead to significant impairment of quality of life through limiting mobility and in its more severe manifestations may lead to severe pain, ulceration and gangrene and is the largest single cause of lower limb amputation in the UK.

Imaging Tests for the Staging of Colorectal Cancer [Internet]

Colorectal cancer is both the third most common type of cancer and the third most common cause of cancer-related death for both men and women. Treatment options for colorectal cancer differ depending on the clinical stage of disease at diagnosis. Our objective was to synthesize the available evidence on the comparative effectiveness of imaging tests for staging colorectal cancer.

PubMed Health Blog...

read all...